| abstract |
These are described herein in compounds that are somatostatin modulators, methods of making the compounds, pharmaceutical compositions and formulations containing the compounds, and the treatment of diseases, disorders, or disorders that would benefit from the regulation of somatostatin activity. Methods of using the compound are described. [Selection diagram] Fig. 1 |